{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:02:04Z","timestamp":1785124924321,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanxi Basic Research Program","award":["202203021212073"],"award-info":[{"award-number":["202203021212073"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03333-3","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:05:06Z","timestamp":1783487106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a lncRNA prognostic signature reveals that SNAI3-AS1 cooperates with erastin to reshape macrophage polarization in glioma"],"prefix":"10.1007","volume":"43","author":[{"given":"Xiaochen","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"3333_CR1","doi-asserted-by":"publisher","first-page":"17049","DOI":"10.1038\/s41598-025-01368-6","volume":"15","author":"B Huangfu","year":"2025","unstructured":"Huangfu B, Liu X, Wang X, Niu X, Wang C, Cheng R, et al. Global trends and burden of brain and central nervous system cancers in adolescents and young adults GBD 2021 study. Sci Rep. 2025;15:17049. https:\/\/doi.org\/10.1038\/s41598-025-01368-6.","journal-title":"Sci Rep"},{"key":"3333_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11060-025-05315-3","volume":"176","author":"B Hsueh","year":"2025","unstructured":"Hsueh B, Steuart SJ, Odukoya AO, Prager BC, Kim YJ, Hill CM, et al. Immunotherapy and targeted therapy for high grade gliomas: current and future directions. J Neurooncol. 2025;176:112. https:\/\/doi.org\/10.1007\/s11060-025-05315-3.","journal-title":"J Neurooncol"},{"key":"3333_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-026-05467-w","volume":"177","author":"C Wang","year":"2026","unstructured":"Wang C, Xu H, Hu Y, Ma L, Ren Q, Yu S. Tumor treating fields for newly diagnosed glioblastoma: a retrospective analysis. J Neurooncol. 2026;177:1. https:\/\/doi.org\/10.1007\/s11060-026-05467-w.","journal-title":"J Neurooncol"},{"key":"3333_CR4","doi-asserted-by":"publisher","first-page":"e18761429274883","DOI":"10.2174\/0118761429274883231129103220","volume":"17","author":"L Li","year":"2024","unstructured":"Li L, Li Y, Zhou X. Advancements in the Research of GEF-H1: Biological Functions and Tumor Associations. Curr Mol Pharmacol. 2024;17:e18761429274883. https:\/\/doi.org\/10.2174\/0118761429274883231129103220.","journal-title":"Curr Mol Pharmacol"},{"key":"3333_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/0113892029300608240531111743","volume":"25","author":"Z Peng","year":"2024","unstructured":"Peng Z, Fang C, Tong Z, Rao Q, Ren Z, Hu K. Crosstalk Between Cancer-associated Fibroblasts and Myeloid Cells Shapes the Heterogeneous Microenvironment of Gastric Cancer. Curr Genomics. 2024;25:390\u2013411. https:\/\/doi.org\/10.2174\/0113892029300608240531111743.","journal-title":"Curr Genomics"},{"key":"3333_CR6","doi-asserted-by":"publisher","first-page":"1754980","DOI":"10.3389\/fcell.2026.1754980","volume":"14","author":"H Fan","year":"2026","unstructured":"Fan H, Yang S, Lu Q, Chang L. Metabolic reprogramming and immunosenescence: a new sight for glioma therapy. Front Cell Dev Biol. 2026;14:1754980. https:\/\/doi.org\/10.3389\/fcell.2026.1754980.","journal-title":"Front Cell Dev Biol"},{"key":"3333_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/0113892029278082240118053857","volume":"25","author":"A Xing","year":"2024","unstructured":"Xing A, Lv D, Wu C, Zhou K, Zhao T, Zhao L, et al. Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma. Curr Genomics. 2024;25:88\u2013104. https:\/\/doi.org\/10.2174\/0113892029278082240118053857.","journal-title":"Curr Genomics"},{"key":"3333_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/0115665232301222240603100840","volume":"25","author":"Q Ye","year":"2025","unstructured":"Ye Q, Li D, Zou Y, Yuan Y. The Role and Treatment Strategies of Ammonia-Related Metabolism in Tumor Microenvironment. Curr Gene Ther. 2025;25:199\u2013209. https:\/\/doi.org\/10.2174\/0115665232301222240603100840.","journal-title":"Curr Gene Ther"},{"key":"3333_CR9","doi-asserted-by":"publisher","first-page":"e70586","DOI":"10.1002\/mco2.70586","volume":"7","author":"X Yin","year":"2026","unstructured":"Yin X, Du Z, Jiang S, Liao Y, Wang C, Li J, et al. RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. MedComm (Beijing). 2026;7:e70586. https:\/\/doi.org\/10.1002\/mco2.70586.","journal-title":"MedComm (Beijing)"},{"key":"3333_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10142-025-01557-6","volume":"25","author":"AS Doghish","year":"2025","unstructured":"Doghish AS, Mahmoud A, Abd-Elmawla MA, Zaki MB, Aborehab NM, Hatawsh A, et al. Innovative perspectives on glioblastoma: the emerging role of long non-coding RNAs. Funct Integr Genomics. 2025;25:43. https:\/\/doi.org\/10.1007\/s10142-025-01557-6.","journal-title":"Funct Integr Genomics"},{"key":"3333_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12935-025-04051-y","volume":"25","author":"Z Jamalpoor","year":"2025","unstructured":"Jamalpoor Z, Aghayan AH, Mirzaei E, Mohammadi D, Atashi A. Assessing the prognostic value of long non-coding RNAs in glioblastoma patients: findings from a systematic review and meta-analysis. Cancer Cell Int. 2025;25:416. https:\/\/doi.org\/10.1186\/s12935-025-04051-y.","journal-title":"Cancer Cell Int"},{"key":"3333_CR12","doi-asserted-by":"publisher","first-page":"1471388","DOI":"10.3389\/fimmu.2024.1471388","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Xu J, Li X, Shi J, Wei C, Liang Q. Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma. Front Immunol. 2024;15:1471388. https:\/\/doi.org\/10.3389\/fimmu.2024.1471388.","journal-title":"Front Immunol"},{"key":"3333_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12967-023-04823-y","volume":"22","author":"J Luan","year":"2024","unstructured":"Luan J, Zhang D, Liu B, Yang A, Lv K, Hu P, et al. Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiforme. J Transl Med. 2024;22:107. https:\/\/doi.org\/10.1186\/s12967-023-04823-y.","journal-title":"J Transl Med"},{"key":"3333_CR14","doi-asserted-by":"publisher","first-page":"112438","DOI":"10.1016\/j.intimp.2024.112438","volume":"137","author":"M Jiang","year":"2024","unstructured":"Jiang M, Liu Y, Zhang T, Ye G, Hong S, Qi Z. Identification of a ferroptosis-related prognostic signature and validation of ITGA6-AS1 in enhancing cell proliferation, migration and invasion in glioma. Int Immunopharmacol. 2024;137:112438. https:\/\/doi.org\/10.1016\/j.intimp.2024.112438.","journal-title":"Int Immunopharmacol"},{"key":"3333_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-023-02684-3","volume":"42","author":"J Zheng","year":"2023","unstructured":"Zheng J, Zhang Q, Zhao Z, Qiu Y, Zhou Y, Wu Z, et al. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1. J Exp Clin Cancer Res. 2023;42:127. https:\/\/doi.org\/10.1186\/s13046-023-02684-3.","journal-title":"J Exp Clin Cancer Res"},{"key":"3333_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-026-01128-z","author":"R Kang","year":"2026","unstructured":"Kang R, Liu J, Wang J, Kroemer G, Tang D. Translating ferroptosis into oncology: challenges, opportunities and future directions. Nat Rev Clin Oncol. 2026. https:\/\/doi.org\/10.1038\/s41571-026-01128-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"3333_CR17","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1021\/acsnano.5c17966","volume":"20","author":"M Wang","year":"2026","unstructured":"Wang M, Lai Y, Meng H, Jin A, Zhang P, Shen Y, et al. Brain-Targeting Metal-Organic Framework Nanoplatform Reprogramming Ferroptosis Sensitivity of Glioblastoma. ACS Nano. 2026;20:2856\u201371. https:\/\/doi.org\/10.1021\/acsnano.5c17966.","journal-title":"ACS Nano"},{"key":"3333_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RGW, McKenna A, Campos B, Noushmehr H, Salama SR, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155:462\u201377. https:\/\/doi.org\/10.1016\/j.cell.2013.09.034.","journal-title":"Cell"},{"key":"3333_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang K-N, Wang Q, Li G, Zeng F, Zhang Y, et al. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genomics Proteom Bioinf. 2021;19:1\u201312. https:\/\/doi.org\/10.1016\/j.gpb.2020.10.005.","journal-title":"Genomics Proteom Bioinf"},{"key":"3333_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","volume":"10","author":"S Singh","year":"2025","unstructured":"Singh S, Dey D, Barik D, Mohapatra I, Kim S, Sharma M, et al. Glioblastoma at the crossroads: current understanding and future therapeutic horizons. Signal Transduct Target Ther. 2025;10:213. https:\/\/doi.org\/10.1038\/s41392-025-02299-4.","journal-title":"Signal Transduct Target Ther"},{"key":"3333_CR21","doi-asserted-by":"publisher","first-page":"118237","DOI":"10.1016\/j.biopha.2025.118237","volume":"189","author":"S Pournajaf","year":"2025","unstructured":"Pournajaf S, Pourgholami MH. The mTOR pathway in Gliomas: From molecular insights to targeted therapies. Biomed Pharmacother. 2025;189:118237. https:\/\/doi.org\/10.1016\/j.biopha.2025.118237.","journal-title":"Biomed Pharmacother"},{"key":"3333_CR22","doi-asserted-by":"publisher","unstructured":"De Fazio E, Pittarello M, Gans A, Ghosh B, Slika H, Alimonti P, et al. Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25052563.","DOI":"10.3390\/ijms25052563"},{"key":"3333_CR23","doi-asserted-by":"publisher","first-page":"1347877","DOI":"10.3389\/fimmu.2024.1347877","volume":"15","author":"A Ballest\u00edn","year":"2024","unstructured":"Ballest\u00edn A, Armocida D, Ribecco V, Seano G. Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features. Front Immunol. 2024;15:1347877. https:\/\/doi.org\/10.3389\/fimmu.2024.1347877.","journal-title":"Front Immunol"},{"key":"3333_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-020-02840-z","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Guo D, Lu G, Mohiuddin Chowdhury ATM, Zhang D, Ren M, et al. LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma. Cell Death Dis. 2020;11:685. https:\/\/doi.org\/10.1038\/s41419-020-02840-z.","journal-title":"Cell Death Dis"},{"key":"3333_CR25","doi-asserted-by":"publisher","first-page":"122911","DOI":"10.1016\/j.biomaterials.2024.122911","volume":"315","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zuo M, Jana D, Zhong W, Tan BSN, Zhang X, et al. Priming of cancer-immunity cycle by alleviating hypoxia-induced ferroptosis resistance and immunosuppression. Biomaterials. 2025;315:122911. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122911.","journal-title":"Biomaterials"},{"key":"3333_CR26","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.7150\/ijbs.115721","volume":"21","author":"W Feng","year":"2025","unstructured":"Feng W, Liu Y, Zhang Q, Hu S, Xie D, Tan P, et al. GDF15 Drives Glioblastoma Radioresistance by Inhibiting Ferroptosis and Remodeling the Immune Microenvironment. Int J Biol Sci. 2025;21:6794\u2013807. https:\/\/doi.org\/10.7150\/ijbs.115721.","journal-title":"Int J Biol Sci"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03333-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T03:46:37Z","timestamp":1785123997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03333-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["3333"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03333-3","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the analyses based on public datasets (TCGA and CGGA), no ethical approval was required. For experiments involving human tissue samples, approval was obtained from the Ethics Committee of Shanxi Provincial People\u2019s Hospital (Approval No. 2023\u2009\u2212\u2009408). All procedures involving human participants were conducted in accordance with the ethical guidelines and regulations of the institution and with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients or their legal guardians prior to sample collection.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of anonymized data derived from the patient samples was obtained from all participants.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"213"}}